Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × cemiplimab × Clear all

NCT04543071 2025-06-19

Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

Phase 2 Recruiting

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

NCT04177810 2024-02-23

Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer

Phase 2 Completed

25 enrolled 9 charts

Gastrointestinal

Pancreatic Neoplasms